Analysis of risk factors associated with complications of hyperbaric oxygen therapy

Ambiru, Satoshi; Furuyama, Nobuaki; Aono, Mitsuo; Otsuka, Hiromi; Suzuki, Teruyuki; Miyazaki, Masaru

doi:10.1016/j.jcrc.2007.08.002

Cited by 24 publications

(19 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Thus, in line with other studies, our female patients tended to have more BTs. Other than sex, we saw no accumulation in parameters that have previously been identified as possible risk factors (10,12,13). This study found that the incidence of BT in our department was very low.…”

Section: Discussionmentioning

confidence: 53%

Hi̇perbari̇k Oksi̇jen Tedavi̇si̇ Kompli̇kasyonu: Semptomati̇k Orta Kulak Ve Kranyal Si̇nus Barotravmasi

Mirasoğlu¹,

Cakkalkurt²,

Çimşit³

2017

İstanbul Tıp Fakültesi Dergisi

View full text Add to dashboard Cite

, 2012, and HBOT log books for the same period were searched for barotraumas. Patients who were intubated and unconscious were excluded. Data about demographics and medical history of conscious patients with barotrauma (BT) were collected and evaluated retrospectively. Results: It was found that over eight years and 23,645 sessions, 39 of a total 896 patients had BT; thus, the general BT incidence of our department was 4.4%. The barotrauma incidence was significantly less in the multiplace chamber (3.1% vs. 8.7%) where a health professional attended the therapies. Most barotraumas were seen during early sessions and were generally mild. A significant accumulation according to treatment indications was not determined. Conclusion: It was thought that the low barotrauma incidence was related to the slow compression rate as well as training patients thoroughly and monitoring them carefully. It can be said that when applied in these conditions, HBOT is safe for ears and cranial sinuses. Key words: Hyperbaric oxygen; barotraumas; patient training. Tedavi sırasında entübe ve bilinci kapalı olan hastalar çalışmadan dışlandı. Hastaların demografik bilgileri ile medikal özellikleri kaydedildi ve değerlendirildi. Bulgular: Sekiz yılda 23.645 seans HBOT yapıldığı ve bu sürede tedavi edilen 896 hastanın 39'unda semptomatik barotravma oluştuğu saptandı. Merkezimizdeki genel BT insidansı %4,4 idi. Bir sağlık görevlisinin tedaviler sırasında hastalara eşlik ettiği çok kişilik basınç odalarında barotravma insidansı (% 3,1) tek kişilik basınç odasına (% 8,7) göre anlamlı şekilde daha azdı. Barotravmaların pek çoğu hastaların tedaviye ilk başladığı dönemlerde oluşmaktaydı ve genel olarak hafif seyirliydi. HBO tedavisine alınma endikasyonu ile barotravma arasında bir ilişki izlenmedi. Sonuç: Yavaş kompresyon hızı ile birlikte hastaların tedavi öncesi eğitilmesi ve tedavi sırasında yakın gözlemin barotravma oluşma sıklığını azalttığı düşünüldü. Bu koşullarda uygulandığında HBO tedavisinin kranyal sinüs ve orta kulak barotravmaları açısından güvenli olduğu söylenebilir. Anahtar kelimeler: hiperbarik oksijen; barotravma; hasta eğitimi

show abstract

Section: Discussionmentioning

confidence: 53%

Hi̇perbari̇k Oksi̇jen Tedavi̇si̇ Kompli̇kasyonu: Semptomati̇k Orta Kulak Ve Kranyal Si̇nus Barotravmasi

Mirasoğlu¹,

Cakkalkurt²,

Çimşit³

2017

İstanbul Tıp Fakültesi Dergisi

View full text Add to dashboard Cite

show abstract

“…Lastly, the patients were treated with repetitive HBOT for a total of 10 sessions (once per day for 2 weeks). According to previous studies, HBOT may be associated with several rare adverse effects, including damage to the ears, sinuses and lungs from the effects of pressure, pneumothorax, air embolism, seizure, and oxygen poisoning [12, 19, 20]. In this study, all patients completed the treatment protocol and very few received myringotomy before HBOT for possible middle ear barotraumas.…”

Section: Discussionmentioning

confidence: 95%

Effects of Repetitive Hyperbaric Oxygen Treatment in Patients with Acute Cerebral Infarction: A Pilot Study

Chen

Wang

et al. 2012

The Scientific World Journal

View full text Add to dashboard Cite

The role of hyperbaric oxygen therapy (HBOT) in the treatment of acute ischemic stroke is controversial. This prospective study assessed the efficacy and safety of HBOT as adjuvant treatment on 46 acute ischemic stroke in patients who did not receive thrombolytic therapy. The HBOT group (n = 16) received conventional medical treatment with 10 sessions of adjunctive HBOT within 3–5 days after stroke onset, while the control group (n = 30) received the same treatment but without HBOT. Early (around two weeks after onset) and late (one month after onset) outcomes (National Institutes of Health Stroke Scale, NIHSS scores) and efficacy (changes of NIHSS scores) of HBOT were evaluated. The baseline clinical characteristics were similar in both groups. Both early and late outcomes of the HBOT group showed significant difference (P ≤ 0.001). In the control group, there was only significant difference in early outcome (P = 0.004). For early efficacy, there was no difference when comparing changes of NIHSS scores between the two groups (P = 0.140) but there was statistically significant difference when comparing changes of NIHSS scores at one month (P ≤ 0.001). The HBOT used in this study may be effective for patients with acute ischemic stroke and is a safe and harmless adjunctive treatment.

show abstract

“…Side effects of HBO therapy include problems in the middle ear pressure equalization, sinus, and tooth squeeze. These complications are correlated strongly to the number of treatment sessions received [28]. Ambiru et al [28] reported a complication rate of 8.1% in patients that received 11-29 treatments, the percentage was higher (17.1%) when the number of HBO treatments was ≥30.…”

Section: Discussionmentioning

confidence: 98%

Short-Term Outcome and MRI Changes in Three Adult Patients with Sickle Cell Disease and Aseptic Osteonecrosis after Treatment with Hyperbaric Oxygen Therapy: A Preliminary Report

et al. 2020

View full text Add to dashboard Cite

Background: Musculoskeletal manifestations are common in sickle cell disease (SCD). Vasoocclusive crisis can manifest acutely as joint and bone pain, osteomyelitis and/or arthritis. It can also lead to chronic bone aches, bone deformities, degenerative arthritis, pathological fractures, and osteoporosis. Hyperbaric oxygen (HBO) therapy is a mode of treatment in which Case Shier et al.: Short-Term Outcome and MRI Changes in Three Adult Patients with SCD and Aseptic ON after Treatment with HBO Therapy 366the patient is exposed to very high arterial and tissue oxygen pressure, during multiple sessions. It has been used as primary or adjunctive therapy for a variety of medical disorders, including necrotizing infection and sickle cell crisis. Case Report: In this case series, 3 patients with SCD and avascular necrosis were treated with 15-40 sessions of HBO and were assessed 6-12 months by MRI after treatment. They showed different clinical outcomes and MRI changes. Conclusion: We concluded that HBO can result in some subjective improvement, especially in early stages. Further studies on severe cases are needed.

show abstract

Analysis of risk factors associated with complications of hyperbaric oxygen therapy

Cited by 24 publications

References 6 publications

Hi̇perbari̇k Oksi̇jen Tedavi̇si̇ Kompli̇kasyonu: Semptomati̇k Orta Kulak Ve Kranyal Si̇nus Barotravmasi

Hi̇perbari̇k Oksi̇jen Tedavi̇si̇ Kompli̇kasyonu: Semptomati̇k Orta Kulak Ve Kranyal Si̇nus Barotravmasi

Effects of Repetitive Hyperbaric Oxygen Treatment in Patients with Acute Cerebral Infarction: A Pilot Study

Short-Term Outcome and MRI Changes in Three Adult Patients with Sickle Cell Disease and Aseptic Osteonecrosis after Treatment with Hyperbaric Oxygen Therapy: A Preliminary Report

Contact Info

Product

Resources

About